Macquarie Group’s Greenwich LifeSciences GLSI Stock Holding History

Macquarie Group’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-110	Closed	-$2	–	1991
2024 Q1	$2	Buy	+110	New	+$1.36K	﹤0.01%	1849

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Macquarie Group's GLSI Position: Q2 2024 in Review

Macquarie Group sold out of Greenwich LifeSciences (GLSI) in Q2 2024, closing a stake of 110 shares — an estimated $2 sold.

Macquarie Group first reported a position in GLSI in Q1 2024 and held it in 1 quarter. The position peaked at $2 in Q1 2024. 34 funds tracked by Wall St. Rank hold GLSI as of Q2 2024.

Macquarie Group reported no remaining Greenwich LifeSciences position as of Q2 2024 after selling out during the quarter.
Macquarie Group sold 110 Greenwich LifeSciences shares in Q2 2024, an estimated $2.
Macquarie Group first reported a position in Greenwich LifeSciences in Q1 2024 and held it in 1 quarter.
Macquarie Group's Greenwich LifeSciences position peaked at $2 in Q1 2024.
34 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.